Can CT Enteroclysis Predict the Outcome of Crohn's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00572780
Recruitment Status : Completed
First Posted : December 13, 2007
Last Update Posted : August 10, 2015
Information provided by (Responsible Party):
Indiana University

Brief Summary:
Specific CT Enteroclysis findings with or without other clinical and laboratory variables, can identify Crohn's disease patients who will response to medical therapy versus those who will either fail and require surgery or have uncontrolled disease.

Condition or disease
Crohn's Disease

Study Type : Observational
Actual Enrollment : 125 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Can CT Enteroclysis Predict the Response to Therapy and Outcome in Patient With Crohn's Disease
Study Start Date : August 2007
Actual Primary Completion Date : January 2012
Actual Study Completion Date : January 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Crohn's Disease
U.S. FDA Resources

CTE with CD
Crohn's disease patients who underwent a CT enteroclysis as part of their clinical evaluation for symptomatic Crohn's disease.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Crohn's disease patients that have had a CT Enteroclysis as part of their clinical evaluation for symptomatic Crohn's disease will be eligible. Subjects who were later diagnosied with bowel malignancy and subjects with a period of follow-up of less than 1 year(without surgery) will be excluded.

Inclusion Criteria:

  • Crohn's disease with CT Enteroclysis during symptomatic treatment

Exclusion Criteria:

  • Crohn's disease subjects who have had a follow-up less than 1 year, without surgery
  • Crohn's disease subjects that were later diagnosed with a bowel malignancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00572780

United States, Indiana
Indiana University
Indianapolis, Indiana, United States, 46202
Sponsors and Collaborators
Indiana University
Principal Investigator: Michael V. Chiorean, M.D. Indiana University

Responsible Party: Indiana University Identifier: NCT00572780     History of Changes
Other Study ID Numbers: 070759
First Posted: December 13, 2007    Key Record Dates
Last Update Posted: August 10, 2015
Last Verified: August 2015

Keywords provided by Indiana University:
Crohn's Disease
CT Enteroclysis

Additional relevant MeSH terms:
Crohn Disease
Inflammatory Bowel Diseases
Gastrointestinal Diseases
Digestive System Diseases
Intestinal Diseases